Published on December 1, 2009 at 4:59 AM
Changda International Holdings (OTCBB: CIHD), the Weifang based specialty chemicals manufacturer has received a first commercial order for it product Thiophene from Sanofi Aventis (NYSE: SNY), the French pharmaceutical multinational. The order was preceded by a rigid due diligence process undertaken by Sanofi on Changda International and its products.
“This development emphasizes our high quality standards and ability to compete on an international level and is a further milestone for our company. It is a further demonstration of how our R&D, product development and market intelligence work together to successfully conquer new markets with new products,” said Mr QinRan Zhu, CEO of the company.
http://www.changdastock.com/